2017
DOI: 10.2147/ijn.s126154
|View full text |Cite
|
Sign up to set email alerts
|

Harnessing supramolecular peptide nanotechnology in biomedical applications

Abstract: The harnessing of peptides in biomedical applications is a recent hot topic. This arises mainly from the general biocompatibility of peptides, as well as from the ease of tunability of peptide structure to engineer desired properties. The ease of progression from laboratory testing to clinical trials is evident from the plethora of examples available. In this review, we compare and contrast how three distinct self-assembled peptide nanostructures possess different functions. We have 1) nanofibrils in biomateri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 41 publications
(27 citation statements)
references
References 122 publications
0
27
0
Order By: Relevance
“…Nonetheless, the structural information we have uncovered for Ac-LLE and Ac-YLD, as well as the self-assembly outcomes due to the single moiety changes to various tripeptides, can potentially be used to provide vital data to design and assemble novel peptide nanostructures. These novel peptide nanostructures can then be assessed under physiological conditions for their applicability in diverse biomedical applications 89 .…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, the structural information we have uncovered for Ac-LLE and Ac-YLD, as well as the self-assembly outcomes due to the single moiety changes to various tripeptides, can potentially be used to provide vital data to design and assemble novel peptide nanostructures. These novel peptide nanostructures can then be assessed under physiological conditions for their applicability in diverse biomedical applications 89 .…”
Section: Discussionmentioning
confidence: 99%
“…However, the main challenge that might hinder the translation to clinical settings remains the antigenicity of the utilized cells and biomaterials that might trigger the body's immunogenic response. 54 These obstacles have been overcome in the present study, as the biocompatibility of the construct has been proved in vitro as well as in vivo. Further studies will be required to provide the intra-articular functional evidence of the construct.…”
Section: Dovepressmentioning
confidence: 94%
“…Various higher order structures have been observed before, including nanotapes, nanotubes, nanoparticles, and nanofibrils 18 21 . Among these nanostructures, nanofibrils play a prominent role in many biomedical applications 22 24 .…”
Section: Introductionmentioning
confidence: 90%